Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass

We tested the hypothesis that pharmacological preconditioning with a newly developed, potent non-adenosine analogue A1AdoR agonist (BR-4935) improves biventricular cardiac and endothelial function after cardiopulmonary bypass.

Bibliographic Details

Main Authors:	Veres, Gábor (Author) , Radovits, Tamás (Author) , Otila, Gildas Romaric (Author) , Hirschberg, Kristóf (Author) , Haider, Helen Rani (Author) , Krieger, Nelli (Author) , Knoll, A. (Author) , Weigang, E. (Author) , Szabolcs, Z. (Author) , Karck, Matthias (Author) , Szabó, Gábor (Author)
Format:	Article (Journal)
Language:	English
Published:	23. März 2010
In:	The thoracic and cardiovascular surgeon Year: 2010, Volume: 58, Issue: 2, Pages: 86-92
ISSN:	1439-1902
DOI:	10.1055/s-0029-1186271
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0029-1186271 Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0029-1186271
Author Notes:	G. Veres, T. Radovits, G. Otila, K. Hirschberg, H. Haider, N. Krieger, A. Knoll, E. Weigang, Z. Szabolcs, M. Karck, G. Szabó